EGFR Mutant Advanced Non-small Cell Lung Cancer
Oncology·MeSH: Neoplasm Metastasis
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
0 drugs in development·0 companies·0 clinical trials
Deep-dive into EGFR Mutant Advanced Non-small Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis